S-1,oxaliplatin

DRUG2 trials

Sponsors

National Cancer Center, Korea, Aiping Zhou

Conditions

S-1 Plus OxaliplatinStomach Neoplasms

Phase 2

Study of Continuous or Intermittent S-1 Combined With Oxaliplatin in Recurrent or Metastatic Gastric Carcinoma

National Cancer Center, KoreaStomach Neoplasms

Start: 2007-07-31End: 2010-08-31Target: 198Updated: 2008-01-07

Efficacy and Safety of S-1 Plus Oxaliplatin in First-line Treatment of Ederly Patients With Advanced Gastric Cancer

Aiping ZhouS-1 Plus Oxaliplatin

Start: 2016-05-11End: 2022-12-01Target: 60Updated: 2021-01-05

Related Papers

Biweekly oxaliplatin plus S1 for Chinese elderly patients with advanced gastric or gastroesophageal junction cancer as the first-line therapy: a single-arm, phase 2 study.

2022-03-096 citations